Teknisk og drift
Denne siden fornyes snart!
Oslo, 16 April 2018: Photocure ASA (OSE: PHO), has published the annual accounts and annual report for the financial year 2017.
The annual accounts and annual report for the financial year 2017 are enclosed with this notification and made available on the company's website, www.photocure.com.
For further information, please contact:
PhotocureCFO Erik DahlTel: +47 450 55 000, Email: email@example.com
About Photocure ASAPhotocure, headquartered in Oslo Norway, is a specialty pharmaceutical company focusing on urology. Based on its unique proprietary Photocure Technology® platform, Photocure is committed to developing and commercializing highly selective and minimally invasive solutions to improve health outcomes for patients worldwide. The company is listed on the Oslo Stock Exchange (OSE: PHO). More information about Photocure is available at www.photocure.com, www.hexvix.com, www.cysview.com.
Nyheten er levert av GlobeNewswire.